Steven H. Rauchman received his M.D. degree from the University of California, San Francisco (Regent’s scholar). He completed his Ophthalmology Residency at Boston University's Medical Center. Dr. Rauchman is board-certified in ophthalmology and was in full-time private practice in comprehensive ophthalmology from 1987 to 2020. He has been the principal investigator or sub-investigator of over one hundred multi-center trials over the last 16 years. He has concentrated on cataracts, glaucoma, and dry eyes. Dr. Rauchman has served as a medical/legal expert witness in the area of traumatic brain injury and the eye over the last 10 years. He has also participated in the peer review of scientific articles in the field of neuroscience. Dr. Rauchman is currently the principal investigator in a large retrospective study of the impact of SSRIs on COVID-19 disease progression. His major collaborator has been Allison B. Reiss M.D., Associate Professor at NYU Langone Hospital, Long Island. Providence Health Care of Southern California has been the other major collaborator. Dr. Rauchman is a member of the Fresno Institute of Neuroscience.

Dr. Lora Kasselman obtained her PhD in Psychology at the City University of New York, Graduate Center, in New York in 2006. In 2015, she began working at NYU Langone Hospital—Long Island as an associate research scientist and in 2019 became an assistant professor of foundations of medicine at the NYU Grossman Long Island School of Medicine. She obtained her MPH in biostatistics and epidemiology from the City University of New York, Graduate School of Public Health in 2020. Dr. Kasselman's research focused on the gut microbiome/probiotics and cognition in health and disease. She is now Research Biostatistician at the Research Institute, Hackensack Meridian Health, and continues to publish with Dr. Reiss and Dr. Rauchman.

Ankita Srivastava is a Research Associate in the Inflammation Laboratory of Dr. Allison Reiss in the Department of Foundations of Medicine, NYU Grossman Long Island School of Medicine. She completed her Ph.D. in 2017 from CSIR-CDRI, India, working on adipose tissue insulin resistance and non-alcoholic fatty liver diseases. She joined NYU in 2018 as a post-doctoral fellow studying a Roux-en-Y gastric bypass model of bariatric surgery in mice. She joined the Reiss lab in April 2023 and, since then, has focused on designing new and effective treatments for neurocognitive disorders, such as Alzheimer’s disease and those induced by hormone deprivation. Her specific interest is in determining the molecular mechanisms underlying the mitochondrial dysfunction that leads to neuronal death. She is also involved in a project characterizing the role of adipose tissue-derived exosomal microRNAs in cardiovascular disease. She has authored numerous publications in high-impact, peer-reviewed journals and presented posters and oral presentations at various conferences.

Joshua De Leon is a Professor at the Department of Medicine and Biomedical Research Institute, NYU Grossman Long Island School of Medicine, Mineola, NY, USA. He received his B.A. in Biology and Philosophy from Franklin and Marshall College in 1984 and his M.D. from the SUNY Downstate School of Medicine in 1988. He completed a residency in internal medicine and a fellowship in clinical and molecular cardiology at the Albert Einstein College of Medicine. He is a practicing cardiologist with extensive clinical experience in managing patients with inflammatory mechanisms underlying their cardiovascular disease and patients with a disordered lipid metabolism. He has been a co-investigator on an American Heart Association-funded study of inflammation in cardiovascular disease and has participated as a site investigator for multiple clinical trials addressing acute coronary syndromes, chronic CAD management, and lipid metabolism and management. He has been listed in Castle Connolly’s “Top Doctors” series for the New York metro area.

Allison B. Reiss, M.D., is an internal medicine physician, an educator, and a molecular biologist who studies the causes and treatment of inflammatory disorders, including Alzheimer’s disease and other forms of cognitive impairment, cardiovascular disease, and rheumatologic disorders. Her research is bench-to-bedside and directed toward finding effective therapies for these disease states. She received her medical degree from SUNY Downstate and completed an Internal Medicine Residency at UMDNJ Rutgers. She is certified by the American Board of Internal Medicine. Dr. Reiss is the Head of The Inflammation Laboratory and Associate Professor of Medicine at the NYU Grossman Long Island School of Medicine. She is well-published in medical and scientific journals and has chaired symposia at national and international conferences. Dr. Reiss is the Section Editor-in-Chief, Neurology, for the journal Medicina. She teaches and mentors medical students, residents, and fellows. She has received funding from the National Institutes of Health, the American Heart Association, and the Arthritis Foundation. She is currently funded by the Alzheimer’s Foundation of America. Dr. Reiss has a strong passion for community outreach and is dedicated to improving healthcare, especially for older populations.